COMBINATORIAL TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MOLECULES AND MELANOMA DIFFERENTIATION ASSOCIATED GENE-7
摘要
The present invention relates to methods of treating a cancer associated with aberrant EGFR-activity comprising administering, to a subject in need of such treatment, an effective amount of a combination of an EGFR inhibitor and a MD A-7 molecule. The combined use of these agents allows effective therapy of cancers that may be relatively resistant to either agent alone.
申请公布号
WO2008063773(A3)
申请公布日期
2008.10.02
申请号
WO2007US80962
申请日期
2007.10.10
申请人
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK;SETTLEMAN, JEFFREY;FISHER, PAUL, B.;EMDAD, LUNI